October 20, 2025 - EverGlade Consulting

October 20, 2025

BARDA’s RPP to Onshore Vaccine Manufacturing for Viral Hemorrhagic Fevers

The Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS), has issued a new Request for Project Proposals (RPP-26-10-VHF) under its Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium). This solicitation represents a key step in building domestic capacity for advanced vaccine manufacturing to strengthen the nation’s biosecurity infrastructure. […]

BARDA’s RPP to Onshore Vaccine Manufacturing for Viral Hemorrhagic Fevers Read More »

ARPA-H THRIVE ISO Amendment 1

THRIVE+ISO_Amendment_No_1_Tracked_Changes (1) Amendment released for ARPA-H’s THRIVE Initiative The Advanced Research Projects Agency for Health (ARPA-H), through its Health Science Futures Office, released Amendment No. 1 for the Treating Hereditary Rare diseases with In Vivo precision genetic mEdicines (THRIVE) Innovative Solutions Opening (ISO) (ARPA-H-SOL-25-122) on October 17, 2025. The updates focus on changes to the

ARPA-H THRIVE ISO Amendment 1 Read More »

Scroll to Top